NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for BioChem Pharma


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Auspex Pharmaceuticals Appoints Michael Grey as Chief Executive Officer and R. Gary Gilmore as Chief Financial Officer
2009 JAN 19 ... to Trega, he was President of BioChem Therapeutic Inc., the pharmaceutical division of BioChem Pharma, Inc., and was President and Chief Operating Officer of Ansan, Inc., an early stage ...
Subject: Auspex Pharmaceuticals, Inc.
Price: $3.00
*
BELLUS Health Inc. Announces $12 Million Rights Offering To Common Shareholders
2009 JUL 20 ... biopharmaceutical industry, six of which stem from his tenure as Corporate Controller at Biochem Pharma. Details of the Rights Offering Assuming exercise of all ...
Subject: Pharmaceuticals
Price: $3.00
*
Enzo Biochem Names Kevin Krenitsky President of Enzo Clinical Labs
2009 MAR 23 ... Enzo Biochem, Inc. (NYSE: ENZ) announced that its Enzo Clinical Labs subsidiary has strengthened its ... in the clinical service, molecular diagnostics, and pre-clinical and clinical pharma, should serve us well as we continue to develop Enzo Clinical Labs into a molecular and ...
Subject: Enzo Biochem, Inc.
Price: $3.00
*
Gentium Announces New Board of Directors and Interim CEO
2009 NOV 23 ... of Canada's Science Technology Innovation Council. Dr. Bellini was co-founder of Biochem Pharma as well as its Chairman and Chief Executive Officer from 1986 until it was sold in 2000. ...
Subject: Gentium S.p.A.
Price: $3.00
*
Global Nanomagnetics Strategic Business Report Analyses the Worldwide Market in Terms of US$ Millions
2009 FEB 17 ... Cathay Pigments (USA) LLC - Cathay Magnetics, Chemagen Biopolymer-Technologie AG, Cortex Biochem, Inc, Dowa Holdings Co., Ltd., EMD Biosciences, Inc, Ferrotec (USA) Corporation, Fujitsu ... Electric Co., Ltd, Amag Pharmaceuticals Inc., Bangs Laboratories, Inc., Bayer Schering Pharma AG, Biophan Technologies, Inc, Cathay Pigments (USA) LLC - Cathay Magnetics, Chemagen ...
Subject: Research and Markets
Price: $3.00
*
One of Canada's Leading Biotech Pioneers Joins Sirona Biochem's Scientific Advisory Board
2009 NOV 16 ... Sirona Biochem Corp. (TSX-V: SBM), an emerging biotech drug development company focused on diabetes and ... will also benefit from Professor Walker's experience as a chief executive of Verona Pharma, which is a publicly listed company in London, UK, as we are also on a path to attract ...
Subject: Obesity and Diabetes
Price: $3.00
*
Reportlinker Adds Global Biotechnology Reagents Market Analysis
2009 MAR 23 ... with Sangamo BioSciences II-34 Fitzgerald Industries Takes Over Cortex Biochem’s Immunoreagent Business II-34 Agilent Technologies ... of Distinct Technologies II-6 Growing Collaboration between Biotech and Pharma Companies II-6 4. Product Overview II-7 A. Classification ...
Subject: ReportLinker
Price: $3.00
*
Reportlinker: Learn about the Shire plc: PharmaVitae Profile
2009 MAY 11 ... Corporation 29Acquisition of Fuisz Technologies' EU susidiaries 29Acquisition of BioChem Pharma 29Acquisition of Atlantic Pharmaceutical 30Divestment of OTC products 30Divestment of ...
Subject: ReportLinker
Price: $3.00
*
Research on angiogenesis reported by scientists at University of Delaware
2009 FEB 9 ... of soluble, biologically active HBGF:HS complexes that activate HBGF receptors. J. Cell. Biochem. 105: 1183-1193, 2008." Dsouza and colleagues published their study in ... Growth Factor, University of Delaware. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2009, Pharma Business ...
Subject: Angiogenesis
Price: $3.00
*
Cytochroma Inc. details recent developments
2007 OCT 16 ... Previous to his experiences on the sellside, he held a number of industry roles at BioChem Pharma and Shire Pharmaceuticals Group plc, including Head of North American Investor ...
Subject: Cytochroma Inc.
Price: $3.00
*
New endocrinology study findings recently were published by scientists in the United States, the Netherlands and Japan
2007 OCT 8 ... (Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes. Biochem Biophys Res Commun, 2006;347(4):1138-1144). For more information, contact ... Like Protein 4, Phosphoinositide 3 Kinase. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Endocrinology
Price: $3.00
*
New findings from University of Massachusetts, U.S., detailed
2007 OCT 8 ... element binding protein 1 gene disruption results in early embryonic lethality. J Cell Biochem, 2006;99(1):140-145). For additional information, contact P.E. Newburger, ... Research, Lethality, RNA Binding Proteins. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: University of Massachusetts, U.S.
Price: $3.00
*
Officials from Cytochroma Inc. report latest developments
2007 OCT 9 ... Previous to his experiences on the sellside, he held a number of industry roles at BioChem Pharma and Shire Pharmaceuticals Group plc, including Head of North American Investor ...
Subject: Cytochroma Inc.
Price: $3.00
*
Officials from Enzo Biochem, Inc., provide details of new developments
2007 OCT 15 ... Officials from Enzo Biochem, Inc., provide details of new developments. This trend article is an ... Enzo Biochem, Mergers, Enzo Biochem Inc. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Enzo Biochem, Inc.
Price: $3.00
*
Reports outline diabetes study results from Belgium, the People's Republic of China and the United States
2007 OCT 15 ... of proteins in kidney, eye, aorta, and serum of diabetic and nondiabetic rats. J Cell Biochem, 2006;99(1):256-268). For additional information, contact W.C. Cho, Queen ... Fatty Acid, Reactive Oxygen Species. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Diabetes
Price: $3.00
*
Research reports on vaccines from the United Kingdom, the United States and the People's Republic of China provide new insights
2007 OCT 8 ... DNA vaccination induced humoral immune response to glycoprotein C of pseudorabies virus. Biochem Biophys Res Commun, 2006;347(4):845-851). For additional information, ... Technology, Proteomics, Virology. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Vaccines
Price: $3.00
*
Researchers from Mexico, Germany and the People's Republic of China report details of new studies and findings in the area of diabetes
2007 OCT 8 ... extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2. Comp Biochem Physiol C Toxicol Pharmacol, 2006;143(4):429-435). For additional ... Pineapple, Tolbutamide, Type 2 Diabetes. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Diabetes
Price: $3.00
*
Studies from Sweden, Kuwait and the United States in the area of diabetes described
2007 OCT 15 ... vasoconstriction to endothelin-1 in the renal arteries of STZ-diabetic rats. Cell Biochem Funct, 2006;24(5):397-405). For more information, contact M.H.M. Yousif, ... Fructose-Lysine, Glycation End Products. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Diabetes
Price: $3.00
*
Study results from France, Canada and the United Kingdom provide new insights into breast cancer
2007 OCT 15 ... (Serum and glucocorticoid-regulated protein kinases: Variations on a theme. J Cell Biochem, 2006;98(6):1391-1407). For additional information, contact J.R. ... Tyrosine Kinase Inhibitor, Women's Health. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: Breast Cancer
Price: $3.00
*
University of Massachusetts, U.S., researchers publish latest findings
2007 OCT 15 ... element binding protein 1 gene disruption results in early embryonic lethality. J Cell Biochem, 2006;99(1):140-145). For additional information, contact P.E. Newburger, ... Research, Lethality, RNA Binding Proteins. This article was prepared by Pharma Business Week editors from staff and other reports. Copyright 2007, Pharma Business ...
Subject: University of Massachusetts, U.S.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login